Drug-induced resistance: nipping it in the ‘budding’
Drug-induced resistance: nipping it in the ‘budding’ |
https://doi.org/10.18632/oncotarget.26328
Aaron Goldman
|
35873-35874 |
Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma
Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma |
https://doi.org/10.18632/oncotarget.26251
Shariful Islam,
Andrew L. Paek,
Michael Hammer,
Savithri Rangarajan,
Robert Ruijtenbeek,
Laurence Cooke,
Eric Weterings,
and Daruka Mahadevan
|
35875-35890 |
Oncolytic properties of non-vaccinia poxviruses
Oncolytic properties of non-vaccinia poxviruses |
https://doi.org/10.18632/oncotarget.26288
Marine Ricordel,
Johann Foloppe,
Christelle Pichon,
Annie Findeli,
Caroline Tosch,
Pascale Cordier,
Sandrine Cochin,
Eric Quémeneur,
Christelle Camus-Bouclainville,
Stéphane Bertagnoli,
and Philippe Erbs
|
35891-35906 |
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway
Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway |
https://doi.org/10.18632/oncotarget.26294
Tiffany J. Rios-Fuller,
Gabriela Ortiz-Soto,
Mercedes Lacourt-Ventura,
Gerónimo Maldonado-Martinez,
Luis A. Cubano,
Robert J. Schneider,
and Michelle M. Martinez-Montemayor
|
35907-35921 |
Syntaxin-1/TI-VAMP SNAREs interact with Trk receptors and are required for neurotrophin-dependent outgrowth
Syntaxin-1/TI-VAMP SNAREs interact with Trk receptors and are required for neurotrophin-dependent outgrowth |
https://doi.org/10.18632/oncotarget.26307
Giulia Fuschini,
Tiziana Cotrufo,
Oriol Ros,
Ashraf Muhaisen,
Rosa Andrés,
Joan X. Comella,
and Eduardo Soriano
|
35922-35940 |
Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells
Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells |
https://doi.org/10.18632/oncotarget.26310
Françoise Boudouresque,
Carole Siret,
Aurélie Dobric,
Françoise Silvy,
Philippe Soubeyran,
Juan Iovanna,
Dominique Lombardo,
and Yolande Berthois
|
35941-35961 |
Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase
Staurosporine, an inhibitor of hormonally up-regulated neu-associated kinase |
https://doi.org/10.18632/oncotarget.26311
Joelle N. Zambrano,
Christina J. Williams,
Carly Bess Williams,
Lonzie Hedgepeth,
Pieter Burger,
Tinslee Dilday,
Scott T. Eblen,
Kent Armeson,
Elizabeth G. Hill,
and Elizabeth S. Yeh
|
35962-35973 |
Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging
Prediction of brain invasion in patients with meningiomas using preoperative magnetic resonance imaging |
https://doi.org/10.18632/oncotarget.26313
Alborz Adeli,
Katharina Hess,
Christian Mawrin,
Eileen Maria Susanne Streckert,
Walter Stummer,
Werner Paulus,
André Kemmling,
Markus Holling,
Walter Heindel,
Rene Schmidt,
Dorothee Cäcilia Spille,
Peter B. Sporns,
and Benjamin Brokinkel
|
35974-35982 |
Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo
Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo |
https://doi.org/10.18632/oncotarget.26316
Markus Friedemann,
Brit Nacke,
Albert Hagelgans,
Carsten Jandeck,
Nicole Bechmann,
Martin Ullrich,
Birgit Belter,
Christin Neuber,
Olga Sukocheva,
Jens Pietzsch,
and Mario Menschikowski
|
35983-35996 |
NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma
NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.26323
Shugo Ueda,
Yoshihiro Miyahara,
Yasuhiro Nagata,
Eiichi Sato,
Taizo Shiraishi,
Naozumi Harada,
Hiroaki Ikeda,
Hiroshi Shiku,
and Shinichi Kageyama
|
35997-36011 |
Brief report on similar mutational changes in neurofibromatosis type 2 gene in minute pulmonary meningothelial-like nodule and meningioma of the central nervous system
Brief report on similar mutational changes in neurofibromatosis type 2 gene in minute pulmonary meningothelial-like nodule and meningioma of the central nervous system |
https://doi.org/10.18632/oncotarget.26325
Mitsunori Higuchi,
Masayuki Watanabe,
Takuya Inoue,
Takumi Yamaura,
Tomoko Suzuki,
Miwako Saito,
Katsunao Niitsuma,
Kotaro Endo,
Ikuro Oshibe,
Nobutoshi Soeta,
Takuro Saito,
Hiroshi Hojo,
Mitsuru Munakata,
and Hiroyuki Suzuki
|
36012-36016 |
Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma
Whole genome duplication is an early event leading to aneuploidy in IDH-wild type glioblastoma |
https://doi.org/10.18632/oncotarget.26330
Blandine Boisselier,
Frédéric Dugay,
Marc-Antoine Belaud-Rotureau,
Anne Coutolleau,
Emmanuel Garcion,
Philippe Menei,
Philippe Guardiola,
and Audrey Rousseau
|
36017-36028 |
Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides
Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides |
https://doi.org/10.18632/oncotarget.26338
Jun Nakata,
Hiroko Nakajima,
Hiromu Hayashibara,
Kanako Imafuku,
Soyoko Morimoto,
Fumihiro Fujiki,
Daisuke Motooka,
Daisuke Okuzaki,
Kana Hasegawa,
Naoki Hosen,
Akihiro Tsuboi,
Yoshihiro Oka,
Atsushi Kumanogoh,
Yusuke Oji,
and Haruo Sugiyama
|
36029-36038 |
Pitfalls on sample preparation for ex vivo imaging of resected cancer tissue using enzyme-activatable fluorescent probes
Pitfalls on sample preparation for ex vivo imaging of resected cancer tissue using enzyme-activatable fluorescent probes |
https://doi.org/10.18632/oncotarget.26320
Ai Mochida,
Fusa Ogata,
Yasuhiro Maruoka,
Tadanobu Nagaya,
Ryuhei Okada,
Fuyuki Inagaki,
Daiki Fujimura,
Peter L. Choyke,
and Hisataka Kobayashi
|
36039-36047 |
Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy |
https://doi.org/10.18632/oncotarget.26373
Toril Holien,
Kristine Misund,
Oddrun Elise Olsen,
Katarzyna Anna Baranowska,
Glenn Buene,
Magne Børset,
Anders Waage,
and Anders Sundan
|
36048-36048 |
Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors
Correction: c-MET receptor as potential biomarker and target molecule for malignant testicular germ cell tumors |
https://doi.org/10.18632/oncotarget.26374
Katia Corano Scheri,
Erica Leonetti,
Luigi Laino,
Vincenzo Gigantino,
Luisa Gesualdi,
Paola Grammatico,
Mariano Bizzarri,
Renato Franco,
J. Wolter Oosterhuis,
Hans Stoop,
Leendert H.J. Looijenga,
Giulia Ricci,
and Angela Catizone
|
36049-36049 |